CPT code 57100 denotes the clinical evaluation of a lesion on the vaginal mucosa with a biopsy performed to obtain tissue for diagnostic pathology. This code captures a common gynecologic diagnostic procedure used to evaluate suspicious lesions, guide clinical management, and determine histologic diagnosis. Nationally, accurate coding of this service affects claims processing, quality reporting, and surveillance of gynecologic conditions.

Key payers in the scope of this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of how the code is defined clinically, typical sites of service, and which payers commonly reimburse for the procedure. The publication also outlines common billing themes, applicable service line context, and where stakeholders should look for policy updates that affect coverage and documentation expectations.

The content is intended to inform billing professionals, clinical staff, and policy analysts about the clinical context and administrative implications of CPT code 57100, provide benchmarking and policy-change awareness, and clarify the service-level definition for consistent coding and reporting. Data not available in the input will be noted where applicable.